ActiveCare® – Your Proven Alternative to Anticoagulant Drugs for DVT Prevention (Deep Vein Thrombosis) from Hospital to Home, with No Major Bleeding
ActiveCare® is a trademark brand of MCS Medical Compression Systems.
ActiveCare® fully meets the American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (ACCP) 2012 Guidelines as standalone therapy without the need of drugs to prevent DVT after total joint replacement for the whole duration of treatment from hospital to home.
ActiveCare® is an economically viable DVT prevention therapy. The system significantly reduces the drug requirements and as such minimizes the occurrence of major bleeding complication and the need for supplementary blood products that may lead to costly readmissions.
ActiveCare® is currently used in more than 80 surgical centers across the country daily. ActiveCare® line of products are cleared for market in several geographies.
Click here to learn more about our clinical studies.
MCS Medical Compression Systems is a medical device company that develops manufactures and markets the brand ActiveCare®, innovative non-invasive solutions for the prevention of Deep Vein Thrombosis (DVT). The company is the first and currently the only to offer the healthcare market a new class of proven Continuous Enhanced Circulation Therapy in combination with MCS’s patented Synchronized Flow Technology (C.E.C.T.® + S.F.T.) devices, which can minimize the need for pharmaceutical therapy as the current standard of care. Founded in 1997, MCS is an Israeli public company, traded on the Tel Aviv Stock Exchange (TASE: MDCL). MCS Inc., the company’s subsidiary, is located in the USA.